![]() | |
![]() | |
Clinical data | |
---|---|
Trade names | Melex, Sedoxil |
Other names | 13-chloro- 2-(2-chlorophenyl)- 5-methyl- 3-oxa- 6,9-diazatricyclo[8.4.0.02,6] tetradeca- 1(10),11,13-trien- 8-one |
AHFS/Drugs.com | International Drug Names |
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status | |
Pharmacokinetic data | |
Metabolism | Liver (CYP3A4) |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChemCID | |
ChemSpider |
|
UNII | |
KEGG |
|
CompTox Dashboard(EPA) | |
Chemical and physical data | |
Formula | C18H16Cl2N2O2 |
Molar mass | 363.24 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Mexazolam[1] (marketed under the trade namesMelex andSedoxil)[2] is a drug which is abenzodiazepine derivative.[3] Mexazolam has been trialed for anxiety and was found to be effective in alleviating anxiety at one week follow-up. Mexazolam is metabolised via theCYP3A4 pathway.HMG-CoA reductase inhibitors includingsimvastatin,simvastatin acid,lovastatin,fluvastatin,atorvastatin andcerivastatin inhibit the metabolism of mexazolam,[4] but not the HMG-CoA reductase inhibitorpravastatin.[5][6] Its principal active metabolites are chlorodesmethyldiazepam (also known as chloronordiazepam ordelorazepam, trade name Dadumir) and chloroxazepam (also known aslorazepam, trade name Ativan).[7]